Obstetrics & Gynecology Ultrasound Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Obstetrics & Gynecology Ultrasound Devices Market is projected to expand from USD 2.21 Billion in 2025 to USD 2.99 Billion by 2031, registering a compound annual growth rate (CAGR) of 5.17%. These specialized diagnostic instruments employ high-frequency sound waves to image the female reproductive system and track fetal development. Market expansion is primarily fueled by the growing incidence of gynecological conditions, such as uterine fibroids and ovarian cysts, as well as an increasing frequency of high-risk pregnancies linked to advanced maternal age. Furthermore, the rising need for early disease identification and consistent prenatal monitoring drives the demand for these essential clinical tools, independent of technological advancements like AI integration.

Conversely, a major impediment to market growth is the worldwide shortage of qualified sonographers and radiologists, which generates bottlenecks in diagnostic workflows. This workforce deficit limits the capacity of healthcare institutions to handle the rising volume of necessary scans. To illustrate, the American Cancer Society estimates that in 2025, approximately 20,890 women in the United States will be diagnosed with ovarian cancer, highlighting the critical and growing requirement for accessible ultrasound diagnostic services to address this disease burden.

Market Drivers

Innovations in 3D/4D imaging and the integration of Artificial Intelligence (AI) are fundamentally transforming the Global Obstetrics & Gynecology Ultrasound Devices Market by improving diagnostic accuracy and clinical efficiency. Manufacturers are increasingly incorporating machine learning algorithms to automate standard fetal measurements, thereby mitigating critical workforce constraints. For example, GE HealthCare's April 2024 press release regarding the 'Voluson Signature Ultrasound Systems' indicates that their new AI-enabled SonoLyst tool can decrease the time needed for standard International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) second-trimester exams by up to 40%. This technological evolution has prompted notable industry investment and consolidation; as reported by MobiHealthNews in May 2024 in the article 'Samsung Medison buying French ultrasound AI startup for $92M', Samsung Medison acquired the fetal ultrasound AI firm Sonio for roughly $92 million to enhance its diagnostic software capabilities.

Simultaneously, the rising prevalence of obstetric and gynecological conditions serves as a primary catalyst for market growth, necessitating frequent and accurate imaging interventions. The growing burden of chronic reproductive health issues and malignancies drives a continuous requirement for high-resolution diagnostic tools to ensure timely treatment. According to the American Cancer Society's 'Cancer Statistics, 2024' report released in January 2024, mortality rates for uterine corpus cancer are rising by 2% annually, a trend that increases clinical reliance on advanced ultrasound systems for early detection and treatment monitoring. This epidemiological pressure guarantees continued demand for specialized imaging equipment designed to handle complex pathologies, distinct from the demand generated by routine obstetric care.

Market Challenges

The global scarcity of skilled sonographers and radiologists represents a formidable obstacle to the expansion of the Obstetrics and Gynecology Ultrasound Devices Market. As healthcare facilities encounter a widening gap between the demand for diagnostic imaging and the availability of qualified personnel to perform scans, significant operational bottlenecks emerge. This deficit directly impacts the market by limiting the volume of procedures hospitals can schedule, thereby reducing the daily utilization rates of existing ultrasound equipment. When diagnostic throughput is capped by human resource limitations rather than patient demand, healthcare providers have less incentive to invest in additional imaging systems, causing procurement departments to delay capital equipment orders.

This workforce crisis is substantiated by recent industry data highlighting the severity of the deficit. According to the Royal College of Radiologists, in 2024, the workforce shortfall for clinical radiology consultants stood at 30%. Such deficiencies result in prolonged wait times for critical prenatal monitoring and gynecological disorder diagnoses, forcing facilities to prioritize emergency cases over routine screenings. For device manufacturers, this inability to scale services effectively curbs revenue growth, as the installation of new machinery becomes financially difficult to justify without the necessary staff to operate it.

Market Trends

The widespread adoption of wireless and handheld ultrasound technologies is democratizing access to obstetric diagnostics by decoupling imaging from traditional cart-based infrastructure. These compact, battery-operated devices allow clinicians to perform immediate fetal assessments at the bedside or in community clinics, significantly reducing the logistical burden of transporting patients to radiology departments. This shift is being accelerated by semiconductor advancements that now enable pocket-sized probes to deliver image quality comparable to larger consoles, expanding their utility beyond simple screening. For instance, according to Butterfly Network, February 2024, in the 'Butterfly Launches Next-Generation Butterfly iQ3' press release, the company introduced its latest ultrasound-on-chip system which delivers double the data processing speed of its predecessor, effectively bridging the performance gap between portable and high-end fixed systems.

Concurrently, the adoption of tele-ultrasound for remote maternal monitoring is transforming the management of high-risk pregnancies by facilitating clinical oversight outside of hospital settings. This model integrates self-operated ultrasound devices with cloud-based platforms, allowing expectant mothers to capture fetal scans at home that are asynchronously reviewed by clinicians to detect complications early. This approach not only alleviates anxiety for patients but also optimizes clinical resources by minimizing unnecessary in-person visits for routine checks. Demonstrating the scaling of this care model, according to Pulsenmore, July 2024, in the 'July 2024 Pulsenmore Newsletter', the company reported surpassing 120,000 remote ultrasound scans utilizing its home-use technology, highlighting the rapid clinical acceptance of decentralized prenatal surveillance.

Key Players Profiled in the Obstetrics & Gynecology Ultrasound Devices Market

• GE Healthcare Technologies Inc.
• Siemens Healthcare Private Limited
• Koninklijke Philips N.V.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• FUJIFILM Corporation
• SamsungHealthcare.com
• Esaote SPA
• CANON MEDICAL SYSTEMS CORPORATION
• CHISON Medical Technologies Co., Ltd.

Report Scope

In this report, the Global Obstetrics & Gynecology Ultrasound Devices Market has been segmented into the following categories:

Obstetrics & Gynecology Ultrasound Devices Market, by Portability:

• Cart/Trolley-Based
• Portable/Handheld

Obstetrics & Gynecology Ultrasound Devices Market, by Product:

• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound

Obstetrics & Gynecology Ultrasound Devices Market, by End Use:

• Hospitals
• Diagnostic Centers
• Others

Obstetrics & Gynecology Ultrasound Devices Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Obstetrics & Gynecology Ultrasound Devices Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.